Skip to main content
main-content

Type 2 diabetes

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

medwireNews editor's pick

Targeting pathophysiology from outset may slow progression to type 2 diabetes

Pills_two types

Upfront treatment with medications that target the underlying pathophysiology of prediabetes may slow patients’ progression to type 2 diabetes, report researchers.

medwireNews editor's pick

IADPSG gestational diabetes criteria predict later dysglycemia

Pregnancy and glucose test

Less stringent criteria for gestational diabetes remain predictive of risk for later prediabetes or type 2 diabetes despite identifying a larger number of women, the HAPO FUS investigators report in JAMA.

Case study

Acute illness while on a SGLT2 inhibitor and ketogenic diet

AdobeStock_88855376

Advisory Board member Theresa Smyth tackles an emergency case involving a type 2 diabetes patient on a new diet and treated with empagliflozin. What went wrong and how should he be managed? [Read more].

Get more on: SGLT2 inhibitors | Diet and nutritional management | Case studies

medwireNews editor's pick

Poor availability, affordability compromise global diabetes medication use

Global health

Diabetes medications are frequently unavailable and unaffordable, particularly in lower-income countries, shows an analysis of the PURE study.

medwireNews editor's pick

Neutral cardiovascular safety for lorcaserin in CAMELLIA-TIMI 61

Heartbeat

The weight-loss medication lorcaserin neither increases nor reduces cardiovascular risk, report the CAMELLIA–TIMI 61 investigators.

medwireNews editor's pick

Ethnicity influences reversibility of dysglycemia in obese children

Teen on weighing scales (symbolic image with model)

Impaired glucose tolerance in obese youths frequently reverts to normal, although the chances of this happening are strongly influenced by ethnicity, researchers report in The Lancet Child & Adolescent Health.

medwireNews editor's pick

ASCEND results question the use of aspirin, omega-3 supplements in diabetes patients

Pills

Findings from a phase IV trial suggest that aspirin use may reduce the risk for primary vascular events but at the cost of increased major bleeding risk in patients with diabetes, while omega-3 fatty acid supplementation does not have a cardioprotective effect.

Expert opinion editorial

Shared decision-making in patient-centered care

Shared decision-making

Is the medical model of care failing diabetes patients in its current form? Advisory Board member Katharine Barnard considers this, and the future of clinical decision support [read more].

Get more on: Psychosocial care | Expert opinion

medwireNews editor's pick

Weight gain after smoking cessation could temporarily increase diabetes risk

Stop smoking
medwireNews editor's pick

Risk factor control may mitigate excess cardiovascular, mortality risk in type 2 diabetes

New Content Item

A study of the Swedish National Diabetes Register suggests that keeping five cardiovascular risk factor variables within the target ranges could offset the excess risk for death, myocardial infarction, or stroke among patients with type 2 diabetes relative to the general population.

medwireNews editor's pick

Research adds to SGLT2 inhibitor amputation risk debate

Pills_two types

Researchers have found evidence to support an increased risk for amputation among patients with type 2 diabetes taking sodium-glucose cotransporter 2 inhibitors relative to some oral treatments.

Expert opinion editorial

Are we using the right tests to diagnose diabetic neuropathy?

Diabetic foot test (symbolic image with models)

Uazman Alam and colleagues interrogate current evidence and real-world clinical scenarios to address whether enough is being done with the tools available to screen and diagnose diabetic neuropathy [read more].

Get more on: Diabetic neuropathy | Management of diabetic foot | Other diabetic complications

medwireNews editor's pick

Real-world bariatric surgery data show microvascular protection

Surgical tools

Obese patients with type 2 diabetes who undergo bariatric surgery achieve large reductions in their risk for microvascular complications, shows a real-world study.

Journal article

Weight management in patients with type 2 diabetes: A multidisciplinary real-world approach

Man checking body fat (symbolic image with model)

This review describes the most effective multidisciplinary approach to weight management in patients with type 2 diabetes in real-world clinical practice [read more].
Hamdy O, Ashrafzadeh S, Mottalib A. Curr Diab Rep 2018; 18: 66. doi: 10.1007/s11892-018-1030-4

Get more on:  Lifestyle interventions | Obesity | Type 2 diabetes

Journal article

Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists

Doctor holding defibrillator (symbolic image with model)

The authors assess the risk of hospitalization due to HF with the use of dipeptidyl peptidase-4 inhibitors compared to glucagon like peptide-1 receptor agonists [read more].
Dawwas GK, Smith SM, Park H. Cardiovasc Diabetol 2018; 17: 102. doi: 10.1186/s12933-018-0746-4

Get more on:  Diabetic complications | Medication | Type 2 diabetes

Expert opinion interview

Barriers to insulin: Management in type 2 diabetes patients

Lori Podcast2

Editorial Board member Lori Berard discusses how to meet and overcome the challenges that follow the initial insulin prescription in patients with type 2 diabetes [listen to the interview 11:53].

Get more on: Expert interviews | Insulin management | Type 2 diabetes

Expert opinion editorial

The right device at the right time: Optimizing the benefit

AdobeStock_64823908

Advisory Board member Katharine Barnard scrutinizes the opinion that clinicians should rely on glycemic outcomes when weighing the decision to prescribe a diabetes device [read more].

Get more on: Devices and technology | Glycemic control in type 1 diabetes | Glycemic control in type 2 diabetes

medwireNews editor's pick

Continuing metformin advisable for patients starting sulfonylurea treatment

Metformin formula

Research shows that starting second-line sulfonylurea treatment is associated with an increased risk for cardiovascular and hypoglycemic events among patients with type 2 diabetes in clinical practice, although the risk is less if they continue using metformin rather than switching completely.

Expert opinion editorial

Tackling clinical inertia: The role of patient engagement

Tackling clinical inertia: The role of patient engagement

Carmen Soto and David Strain provide their insights on clinical inertia in diabetes care and present the co-production model of open communication as an innovative means to address this widespread clinical issue [read more].

Get more on: Medication adherence | Pediatrics | Psychosocial care | Type 1 diabetes | Type 2 diabetes

Journal article

The optimal blood pressure target in diabetes mellitus: A quest coming to an end?

Nurse measuring blood pressure (symbolic image with models)

This review presents the evidence from old and recent trials relevant to optimal blood pressure levels in diabetes mellitus, aiming to shed light in this major clinical question [read more].
Papadopoulou E et al. J Hum Hypertens 2018. doi: 10.1038/s41371-018-0079-5

Get more on:  Diabetic complications | Type 2 diabetes

09-12-2018 | Diet | Commentary | Article

Diet–drug interactions: Why two rights can make a wrong

Editorial Board member and Endocrinologist, Sanjay Kalra comments on the issues raised by a clinical case involving sodium glucose cotransporter 2 inhibitor therapy alongside a restrictive diet.

09-06-2018 | SGLT2 inhibitors | Patient perspective | Article

Living with type 2 diabetes: Patient commentary in response to the paper ‘SGLT2 inhibitors in type 2 diabetes management: Key evidence and implications for clinical practice’

A patient discusses their experience of living with type 2 diabetes, including their experience of diagnosis and self-management, education and adoption of SGLT2 inhibitors to treat the disease.

04-17-2018 | DPP-4 inhibitors | At a glance | Article

Round up of the DPP-4 inhibitor CV outcome trials

medwireNews provides a brief overview of the published and ongoing dipeptidyl peptidase-4 inhibitorscardiovascular outcomes trials.

Downloadable slides

12-21-2017 | Collection

FreeStyle Libre collection

These slide sets summarize the results of randomized controlled trials investigating the use of flash glucose-sensing technology in patients with diabetes.

Funded by an educational grant from Abbott Diabetes Care

Themed collections

06-25-2018 | SGLT2 inhibitors | Themed collection | Collection

Sodium-glucose cotransporter-2 inhibitors in type 2 diabetes

An updated collection of articles focusing on the mechanism of action and clinical use of sodium-glucose cotransporter-2 inhibitors in patients with diabetes.

Journal articles and book chapters

Guidelines

A convenient single access point, providing diabetes professionals with links to a comprehensive set of clinical practice guidelines from a wide range of relevant organizations.

Slides

Downloadable PowerPoint slide sets containing a variety of high-quality images and illustrations from Springer Nature’s library of published figures.

Practice tips

Practical information, guidance, and helpful resources for diabetes healthcare providers. Comprised of practical approaches, case studies, and more.

Themed collections

Compendia of selected, recently published, free full-text journal and book content from Springer Nature and other publishers on a particular topic within diabetes management, as recommended by our Editorial Board.

Independent Medical Education

Educational programs building upon the most current research and professional practice recommendations, with the aim of enabling more efficient diagnosis, optimizing treatment, and improving patient outcomes.

image credits